Nyxoah (STU:5YI) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:5YI Nyxoah SA STU:5YI
61 GF Score
Price €1.42
GF Value €26.24
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Nyxoah Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:5YI
61GF Score
Nyxoah SA STU:5YI
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nyxoah (STU:5YI) Overvalued in 2026?

Based on GuruFocus' analysis, Nyxoah stock appears to be undervalued. The current stock price of €1.42 is trading 94.6% below its estimated GF Value™ of €26.24. GuruFocus considers Nyxoah to be Possible Value Trap.

Key valuation signals for STU:5YI:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €26.24 vs. price of €1.42 (94.6% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the STU:5YI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nyxoah Business Description

Other Exchanges NYXH:USANYXH:Belgium
Address Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
61GF Score

Get the complete analysis for STU:5YI

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.42
Price
€26.24
GF Value